TOP > 外国特許検索 > PEPTIDE THAT SPECIFICALLY ACCUMULATES IN BILIARY TRACT CANCER, AND USE THEREOF

PEPTIDE THAT SPECIFICALLY ACCUMULATES IN BILIARY TRACT CANCER, AND USE THEREOF

外国特許コード F170009073
整理番号 (S2015-1988-N26)
掲載日 2017年5月29日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2016JP078607
国際公開番号 WO 2017057450
国際出願日 平成28年9月28日(2016.9.28)
国際公開日 平成29年4月6日(2017.4.6)
優先権データ
  • 特願2015-196227 (2015.10.1) JP
発明の名称 (英語) PEPTIDE THAT SPECIFICALLY ACCUMULATES IN BILIARY TRACT CANCER, AND USE THEREOF
発明の概要(英語) The present invention provides a novel peptide that specifically accumulates in biliary tract cancer. The peptide according to the present invention is (a) a peptide having an amino acid sequence containing a sequence represented by SEQ ID NO. 1, or (b) a peptide having an amino acid sequence containing a sequence having an identity of 60% or more with respect to the sequence represented by SEQ ID NO. 1, and specifically accumulates in biliary tract cancer.
特許請求の範囲(英語) [claim1]
1. (A) below or (b) peptide.
(A) The peptide which consists of the amino acid arrangement which includes the arrangement which is displayed with arrangement number 1,
(B) The peptide which consists of the amino acid arrangement which includes the arrangement to which arrangement and the identity which are displayed with arrangement number 1 are 60% or more at the same time, possesses unique accumulation characteristic in the gallbladder road cancer
[claim2]
2. In the claim 1 which is annular structure the peptide of statement.
[claim3]
3. Furthermore, in the claim 1 which provides the cystein residue for N end and C end or 2 the peptide of statement.
[claim4]
4. Either of the claim 1-3 which is the Retro-Inverso type which is substituted in D body amino acid in one section the peptide of statement.
[claim5]
5. Either of the claim 1-4 in one section the nuclear acid which features that the cord/code it does the peptide of statement.
[claim6]
6. The vector which features that the nuclear acid of statement is included in claim 5.
[claim7]
7. Either of the claim 1-4 the carrier which features that the peptide of statement is included in one section.
[claim8]
8. Furthermore, in the claim 7 which has the sign substance or the decoration substance the carrier of statement.
[claim9]
9. The aforementioned sign substance, in the claim 8 which is the stable isotope, the radioisotope or the fluorophor the carrier of statement.
[claim10]
10. The aforementioned decoration substance, in the claim 8 which is the sugar chain or polyethylene glycol or 9 the carrier of statement.
[claim11]
11. Either of the claim 7-10 the medicine composition which features the carrier of statement and that it has the bioactive substance in one section.
[claim12]
12. For gallbladder road cancer remedy or it is for diagnosis, in claim 11 the medicine composition of statement.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • NIIGATA UNIVERSITY
  • 発明者(英語)
  • KONDO EISAKU
  • SAITO KEN
国際特許分類(IPC)
指定国 (WO201757450)
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記「問合せ先」までお問い合わせください。

PAGE TOP

close
close
close
close
close
close